ZD-4009, a novel B-cell lymphoma 9 inhibitor, is associated with ameliorated pulmonary fibrosis and reduced hypoxia-inducible fac 1α-mediated glycolysis and transforming growth factor-β/SMAD signaling
Li, Anqi; Zhu, Yuanyuan; Yang, Fan; Li, Yunlu; Dong, Yuxuan; Liu, Cuiting; Zhang, Daizhou; Lu, Wei; Zhao, Yujun; Yan, Peiyu; Gao, Li; Yang, Xinrong; Okhrimenko, Ivan; Xian, Yanfang; Wang, Jianxin; Zhu, Di; Feng, Mei
Share
Save